Article Details
Retrieved on: 2024-06-18 13:22:08
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Bucking its recent winning streak in oncology, AstraZeneca reported Tuesday that its AKT inhibitor Truqap failed to significantly boost overall ...
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here